---
title: Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
date: '2024-02-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38329148/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240208170712&v=2.18.0
source: N Engl J Med
description: 'CONCLUSIONS: Tenecteplase therapy that was initiated 4.5 to 24 hours
  after stroke onset in patients with occlusions of the middle cerebral artery or
  internal carotid artery, most of whom had undergone endovascular thrombectomy, did
  not result in better clinical outcomes than those with placebo. The incidence of
  symptomatic intracerebral hemorrhage was similar in the two groups. (Funded by Genentech;
  TIMELESS ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Tenecteplase therapy that was initiated 4.5 to 24 hours after stroke onset in patients with occlusions of the middle cerebral artery or internal carotid artery, most of whom had undergone endovascular thrombectomy, did not result in better clinical outcomes than those with placebo. The incidence of symptomatic intracerebral hemorrhage was similar in the two groups. (Funded by Genentech; TIMELESS ClinicalTrials.gov number, ...